Miglietta, D., De Palma, C., Sciorati, C., Vergani, B., Pisa, V., Villa, A., . . . Clementi, E. (2015). Naproxcinod shows significant advantages over naproxen in the mdx model of Duchenne Muscular Dystrophy. Orphanet J Rare Dis.

Miglietta, Daniela, Clara De Palma, Clara Sciorati, Barbara Vergani, Viviana Pisa, Antonello Villa, Ennio Ongini, and Emilio Clementi. "Naproxcinod Shows Significant Advantages Over Naproxen in the Mdx Model of Duchenne Muscular Dystrophy." Orphanet J Rare Dis 2015.

Miglietta, Daniela, et al. "Naproxcinod Shows Significant Advantages Over Naproxen in the Mdx Model of Duchenne Muscular Dystrophy." Orphanet J Rare Dis 2015.